©The Author(s) 2018.
World J Gastroenterol. May 7, 2018; 24(17): 1859-1867
Published online May 7, 2018. doi: 10.3748/wjg.v24.i17.1859
Published online May 7, 2018. doi: 10.3748/wjg.v24.i17.1859
Table 1 Risk factors and predictors of fibrostenosing Crohn’s disease
| Clinical[4] | Age at diagnosis < 40 yr |
| Perianal disease at diagnosis | |
| Need for steroids during first flare | |
| Small bowel disease location | |
| Prior appendectomy | |
| Environmental[4] | Smoking |
| Endoscopic[4] | Deep mucosal ulcerations |
| Genetic[4] | Nucleotide oligomerisation domain 2 (NOD2) variants |
| Janus-associated kinase 2 (JAK2) | |
| Caspase-recruitment domain 15 (CARD15) | |
| NOD2/CARD15 mutations on both chromosomes | |
| TNF superfamily 15 (TNFSF15) in Asians | |
| 5T5T in the MMP3 gene | |
| rs1363670 | |
| Serological[4] | Antimicrobial antibodies |
| anti-Saccharomyces cerevisiae antibodies (ASCA) IgA in Asians |
- Citation: Bessissow T, Reinglas J, Aruljothy A, Lakatos PL, Van Assche G. Endoscopic management of Crohn’s strictures. World J Gastroenterol 2018; 24(17): 1859-1867
- URL: https://www.wjgnet.com/1007-9327/full/v24/i17/1859.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i17.1859